{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T01:27:27Z","timestamp":1771637247600,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007048","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.vaccine.2024.126592","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T17:52:06Z","timestamp":1733939526000},"page":"126592","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Seroconversion following PPSV23 vaccination in children with type 1 diabetes mellitus"],"prefix":"10.1016","volume":"45","author":[{"given":"Elizabeth","family":"Ender","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avni","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seema","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Hentz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Creo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.126592_bb0005","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2024.126592_bb0010","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","year":"2018","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.vaccine.2024.126592_bb0015","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/cid\/ciu348","article-title":"Risk of pneumococcal disease in children with chronic medical conditions in the era of pneumococcal conjugate vaccine","volume":"59","author":"Pelton","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2024.126592_bb0020","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1086\/431521","article-title":"The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults","volume":"192","author":"Kyaw","year":"2005","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2024.126592_bb0025","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/thx.2010.136317","article-title":"The influence of pre-existing diabetes mellitus on the host immune response and outcome of pneumonia: analysis of two multicentre cohort studies","volume":"65","author":"Yende","year":"2010","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.vaccine.2024.126592_bb0030","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00125-013-3112-9","article-title":"Effect of hyperglycaemia on inflammatory and stress responses and clinical outcome of pneumonia in non-critical-care inpatients: results from an observational cohort study","volume":"57","author":"Schuetz","year":"2014","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.vaccine.2024.126592_bb0035","doi-asserted-by":"crossref","first-page":"871","DOI":"10.4065\/84.10.871","article-title":"Incidence of invasive pneumococcal disease among children after introduction of a 7-valent pneumococcal conjugate vaccine: a population-based study in Olmsted County","volume":"84","author":"Tsigrelis","year":"2009","journal-title":"Minnesota Mayo Clinic proceed"},{"issue":"12","key":"10.1016\/j.vaccine.2024.126592_bb0040","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.mayocp.2022.06.037","article-title":"Changing trends of invasive pneumococcal Disease in the era of conjugate pneumococcal vaccination in Olmsted County: a population-based study","volume":"97","author":"Chesdachai","year":"2022","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.vaccine.2024.126592_bb0045","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jinf.2009.07.004","article-title":"Trends in invasive pneumococcal disease among older adults in Olmsted County","volume":"59","author":"Tsigrelis","year":"2009","journal-title":"Minnesota J Infect"},{"key":"10.1016\/j.vaccine.2024.126592_bb0050","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.15585\/mmwr.mm7239a5","article-title":"Recommendations for use of 20-valent pneumococcal conjugate vaccine in children \u2014 United States, 2023","volume":"72","author":"Updates","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2024.126592_bb0060","doi-asserted-by":"crossref","DOI":"10.1590\/s1980-220x2016049103249","article-title":"Children with type 1 diabetes mellitus: access to special immunobiological and child care","volume":"51","author":"Wolkers","year":"2017","journal-title":"Rev Esc Enferm USP"},{"key":"10.1016\/j.vaccine.2024.126592_bb0065","first-page":"1","article-title":"Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the advisory committee on immunization practices (ACIP)","volume":"59","author":"Nuorti","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2024.126592_bb0070","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1542\/peds.2004-2312","article-title":"Safety and immunogenicity of the American Academy of Pediatrics-recommended sequential pneumococcal conjugate and polysaccharide vaccine schedule in pediatric solid organ transplant recipients","volume":"116","author":"Lin","year":"2005","journal-title":"Pediatrics"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2024.126592_bb0075","first-page":"962","article-title":"Immunogenicity of pneumococcal conjugate vaccine in pediatric cardiac transplant recipients","volume":"82","author":"Barton","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.vaccine.2024.126592_bb0080","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0022-3476(98)70235-5","article-title":"Combined schedule of 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal vaccine in children and young adults with sickle cell disease","volume":"133","author":"Vernacchio","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2024.126592_bb0085","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/INF.0b013e31814614c6","article-title":"Immunogenicity and safety of a pneumococcal conjugate 7-valent vaccine in infants with sickle cell disease","volume":"26","author":"Reinert","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2024.126592_bb0090","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/01.inf.0000237830.33228.c3","article-title":"Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy","volume":"25","author":"Abzug","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2024.126592_bb0095","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00006454-199603000-00003","article-title":"Comparison of the safety and immunogenicity of a pneumococcal conjugate with a licensed polysaccharide vaccine in human immunodeficiency virus and nonhuman immunodeficiency virus-infected children","volume":"15","author":"King","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2024.126592_bb0100","first-page":"220","article-title":"Immunogenicity of the 23-valent pneumococcal vaccine in children with chronic renal disease","volume":"52","author":"Campins Mart\u00ed","year":"2000","journal-title":"An Esp Pediatr"},{"issue":"4","key":"10.1016\/j.vaccine.2024.126592_bb0105","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.aller.2016.01.003","article-title":"Response to pneumococcal polysaccharide vaccine in children with asthma, and children with recurrent respiratory infections, and healthy children","volume":"44","author":"Quezada","year":"2016","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"2","key":"10.1016\/j.vaccine.2024.126592_bb0110","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13118","article-title":"Response to pneumococcal conjugate and polysaccharide vaccination in children with rheumatic disease","volume":"95","author":"Jensen","year":"2022","journal-title":"Scand J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2024.126592_bb0115","first-page":"CD012306","article-title":"Conjugated pneumococcal vaccine versus polysaccharide pneumococcal vaccine for prevention of pneumonia and invasive pneumococcal disease in immunocompetent and immunocompromised adults and children","author":"Golos","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vaccine.2024.126592_bb0120","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1006\/clim.2002.5220","article-title":"Impaired primary immune response in type-1 diabetes: results from a controlled vaccination study","volume":"103","author":"Eibl","year":"2002","journal-title":"Clin Immunol"},{"key":"10.1016\/j.vaccine.2024.126592_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210839","article-title":"Identification and functional characterization of CD8+ T regulatory cells in type 1 diabetes patients","volume":"14","author":"Pellegrino","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.126592_bb0130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0008-8749(03)00043-1","article-title":"Impaired primary immune response in type-1 diabetes. Functional impairment at the level of APCs and T-cells","volume":"221","author":"Spatz","year":"2003","journal-title":"Cell Immunol"},{"key":"10.1016\/j.vaccine.2024.126592_bb0135","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1128\/CVI.00400-16","article-title":"Antibody responses to immunizations in children with type I diabetes mellitus: a case-control study","volume":"23","author":"Eisenhut","year":"2016","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2024.126592_bb0140","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1016\/j.vaccine.2021.04.015","article-title":"Pneumococcal serotype- specific cut offs based on antibody response to pneumococccal polysaccharide vaccination in healthy adults","volume":"39","author":"Park","year":"2021","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2024.126592_bb0145","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap) - a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.vaccine.2024.126592_bb0150","series-title":"The data analysis for this paper was generated using SAS software, Version 9.4 for Linux. Copyright \u00a9","year":"2022"},{"issue":"130","key":"10.1016\/j.vaccine.2024.126592_bb0155","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2012.07.002","article-title":"Use and Interpertation of diagnostic vaccination in primary immunodeficiency: a working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma, and Immunology","volume":"12","author":"Orange","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126592_bb0160","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/thoraxjnl-2019-213725","article-title":"Pneumococcal serotype trends, surveillance and risk factors in UK adult pneumonia, 2013-18","volume":"75","author":"Pick","year":"2020","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.vaccine.2024.126592_bb0165","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/cid\/ciab307","article-title":"The evolution and distribution of pneumococcal serotypes in adults hospitalized with community-acquired pneumonia in Spain using a serotype-specific urinary antigen detection test: the CAPA study, 2011-2018","volume":"73","author":"Torres","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2024.126592_bb0170","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/cid\/ciab375","article-title":"Expanded analysis of 20 pneumococcal serotypes associated with radiographically confirmed community-acquired pneumonia in hospitalized US adults","volume":"73","author":"Isturiz","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126592_bb0175","first-page":"45(1)","article-title":"Glycemic targets: standards of medical Care in Diabetes","volume":"2021","author":"American Diabetes Association Professional Practice Committee","year":"2022","journal-title":"Diabetes Care"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2401274X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2401274X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T15:12:45Z","timestamp":1739200365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2401274X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":34,"alternative-id":["S0264410X2401274X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126592","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seroconversion following PPSV23 vaccination in children with type 1 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126592","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"126592"}}